Celltrion, Inc. Share Price

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. 23:00:00 19/05/2024 BST 5-day change 1st Jan Change
187,000 KRW -2.35% Intraday chart for Celltrion, Inc. -1.99% -7.20%

Financials

Sales 2024 * 3,534B 2.59B 204B Sales 2025 * 4,201B 3.08B 243B Capitalization 38,563B 28.31B 2,229B
Net income 2024 * 552B 405M 31.9B Net income 2025 * 1,126B 826M 65.07B EV / Sales 2024 * 11.1 x
Net Debt 2024 * 544B 399M 31.44B Net cash position 2025 * 261B 192M 15.08B EV / Sales 2025 * 9.12 x
P/E ratio 2024 *
72.5 x
P/E ratio 2025 *
35.3 x
Employees 2,034
Yield 2024 *
0.23%
Yield 2025 *
0.25%
Free-Float 66.01%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.35%
1 week-1.99%
Current month-1.06%
1 month+8.16%
3 months+3.95%
6 months+10.06%
Current year-7.20%
More quotes
1 week
184 700.00
Extreme 184700
195 400.00
1 month
174 700.00
Extreme 174700
197 000.00
Current year
169 700.00
Extreme 169700
241 000.00
1 year
131 000.00
Extreme 131000
241 000.00
3 years
131 000.00
Extreme 131000
283 276.77
5 years
121 026.29
Extreme 121026.2888
372 915.00
10 years
27 751.54
Extreme 27751.5426
372 915.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 23/04/07
Director of Finance/CFO 49 -
Chairman 66 -
Members of the board TitleAgeSince
Director/Board Member 73 -
Chairman 66 -
Director/Board Member 66 -
More insiders
Date Price Change Volume
20/05/24 187,000 -2.35% 529,601
17/05/24 191,500 -0.78% 1,000,223
16/05/24 193,000 +1.10% 466,199
14/05/24 190,900 +0.05% 277,583

End-of-day quote Korea S.E., May 19, 2024

More quotes
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
187,000 KRW
Average target price
232,471 KRW
Spread / Average Target
+24.32%
Consensus
  1. Stock Market
  2. Equities
  3. A068270 Stock